Olimel N9 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N9 provides amino acid supplementation that supports several clinical situations where protein intake is compromised.

• Post‑operative recovery: helps maintain nitrogen balance and tissue repair.
• Chronic kidney disease management: assists in managing amino‑acid loss during dialysis.
• Severe malnutrition: contributes to rebuilding lean body mass.
• Inherited metabolic disorders: supplies specific amino acids that may be deficient.
• Critical illness or trauma: supports heightened protein turnover.

• The amino acids in Olimel N9 are absorbed through the gastrointestinal tract and enter the systemic circulation, where they serve as substrates for protein synthesis, act as precursors for neurotransmitters and metabolic intermediates, and help regulate nitrogen balance. By providing a balanced profile of essential and non‑essential amino acids, the formulation supports cellular growth, tissue repair and metabolic homeostasis.

Adverse reactions to amino‑acid mixtures are generally uncommon but may occur.

Common Side Effects

• Nausea: mild stomach upset after ingestion.
• Diarrhea: loose stools in sensitive individuals.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Hyperammonemia: elevated blood ammonia in patients with severe liver dysfunction.
• Metabolic imbalance: abnormal electrolyte or acid‑base changes in vulnerable patients.
• Severe gastrointestinal intolerance: persistent vomiting or severe diarrhea requiring medical attention.

When prescribing Olimel N9, clinicians should consider patient‑specific factors and follow standard safety practices.

• Renal impairment: adjust dosage based on renal function and monitor nitrogen waste.
• Hepatic dysfunction: assess risk of hyperammonemia and monitor liver enzymes.
• Pregnancy and lactation: use only if clearly needed; weigh potential benefits against risks.
• Pediatric use: dose must be calculated by weight and supervised by a specialist.
• Concomitant nutrition therapy: avoid excessive total protein intake.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can interact with certain medicines, altering absorption or metabolic pathways.

Major Interactions (Avoid)

• Levothyroxine: amino acids may reduce oral absorption; separate dosing by at least 4 hours.
• Certain antibiotics (e.g., quinolones): chelation may diminish efficacy.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): may affect plasma amino‑acid levels.
• Diuretics: increased renal loss of electrolytes may require monitoring.
• Insulin therapy: enhanced protein intake can modify glucose control.
• Iron supplements: concurrent intake may reduce amino‑acid absorption.